Daniela Etro

541 total citations
10 papers, 394 citations indexed

About

Daniela Etro is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Daniela Etro has authored 10 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Daniela Etro's work include PI3K/AKT/mTOR signaling in cancer (6 papers), Hemophilia Treatment and Research (3 papers) and Blood properties and coagulation (2 papers). Daniela Etro is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), Hemophilia Treatment and Research (3 papers) and Blood properties and coagulation (2 papers). Daniela Etro collaborates with scholars based in Italy, United States and Germany. Daniela Etro's co-authors include Francesco Bernardi, K. Wulff, Angelika Bátorová, Alberto Dolce, Jean‐François Schved, Guglielmo Mariani, Jørgen Ingerslev, Falko H. Herrmann, Flora Peyvandi and Günter Auerswald and has published in prestigious journals such as Blood, The International Journal of Biochemistry & Cell Biology and Thrombosis and Haemostasis.

In The Last Decade

Daniela Etro

10 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Etro Italy 6 259 106 64 57 26 10 394
Sara Vieira Portugal 9 164 0.6× 112 1.1× 42 0.7× 106 1.9× 50 1.9× 14 334
María Larrosa-García Spain 3 192 0.7× 135 1.3× 19 0.3× 78 1.4× 29 1.1× 12 290
Aurélie Pétain France 8 134 0.5× 100 0.9× 35 0.5× 68 1.2× 126 4.8× 18 320
Maohong Zhang China 9 152 0.6× 104 1.0× 23 0.4× 29 0.5× 29 1.1× 20 305
Aytug Kizilors United Kingdom 10 182 0.7× 131 1.2× 17 0.3× 94 1.6× 20 0.8× 21 298
Yunfeng Shen China 12 101 0.4× 111 1.0× 18 0.3× 96 1.7× 60 2.3× 29 309
Masayuki Shiba Japan 11 125 0.5× 66 0.6× 71 1.1× 42 0.7× 13 0.5× 40 376
Maria Cioch Poland 10 123 0.5× 83 0.8× 23 0.4× 38 0.7× 98 3.8× 30 301
Mariateresa Pettinato Italy 8 119 0.5× 87 0.8× 46 0.7× 101 1.8× 42 1.6× 18 264
A. Hitz Germany 3 204 0.8× 122 1.2× 11 0.2× 40 0.7× 39 1.5× 8 354

Countries citing papers authored by Daniela Etro

Since Specialization
Citations

This map shows the geographic impact of Daniela Etro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Etro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Etro more than expected).

Fields of papers citing papers by Daniela Etro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Etro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Etro. The network helps show where Daniela Etro may publish in the future.

Co-authorship network of co-authors of Daniela Etro

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Etro. A scholar is included among the top collaborators of Daniela Etro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Etro. Daniela Etro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Etro, Daniela, et al.. (2011). AKT1 (v-akt murine thymoma viral oncogene homolog 1). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 1 indexed citations
2.
Buontempo, Francesca, Tülin Erşahin, Şerif Şentürk, et al.. (2010). Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status. Investigational New Drugs. 29(6). 1303–1313. 47 indexed citations
3.
Dahlhaus, Meike, Francesca Amoroso, Sandra Lange, et al.. (2010). The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells. BMC Cancer. 10(1). 560–560. 45 indexed citations
4.
Etro, Daniela, et al.. (2008). Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells. The International Journal of Biochemistry & Cell Biology. 41(3). 570–577. 21 indexed citations
5.
Mariani, Guglielmo, Falko H. Herrmann, Alberto Dolce, et al.. (2005). Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thrombosis and Haemostasis. 93(3). 481–487. 174 indexed citations
6.
Bellacosa, Alfonso, Daniela Etro, & Luca M. Neri. (2005). Mutations of thePIK3CAgene in ovarian and breast cancer. The Women s Oncology Review. 5(4). 223–225. 4 indexed citations
7.
Bellacosa, Alfonso, Daniela Etro, & Luca M. Neri. (2005). Mutations of the PIK3CA gene in ovarian and breast cancer. The Women s Oncology Review. 5(4). 223–225. 1 indexed citations
8.
Mariani, Giuliano, F. H. Herrmann, Sam Schulman, et al.. (2003). Thrombosis in inherited factor VII deficiency. Journal of Thrombosis and Haemostasis. 1(10). 2153–2158. 79 indexed citations
9.
Pinotti, Mirko, Daniela Etro, M. L. Papa, et al.. (2002). Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser). Blood. 99(4). 1495–1497. 21 indexed citations
10.
Pedretti, Roberto F.E., et al.. (1992). Role of heart rate variability in patients at high risk of arrhythmic events after acute myocardial infarction. 8. 433–436. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026